Introduction. The distribution of HPV genotypes in women can aid in the selection of an appropriate screening test for detection of HPV infection. For example, identifi cation of particular HPV genotypes strains may reveal patients at high-risk. The purpose of this study was to determine the range and frequency of HPV genotypes in women in Montenegro. Methods. Cervical smears were taken at the Gynecological Department of the Clinical Center in Podgorica from women with clinical signs of HPV infection. HPV genotypes were determined using PCR amplifi cation and enzyme restriction. PCR products were amplifi ed with group-specifi c primers MY09/MY11 and restricted with seven different endonucleases. Patterns of restriction fragment length polymorphism (RFLP) were compared to predefi ned standard patterns. Results. We tested a total of 189 women and found HPV infection in 1/5 of them (20%). Among those infected (38 HPV DNA positive women), there were 16 different HPV genotypes. Genotyping of this group showed that a third of them had HPV genotype 16. The second most frequent HPV infection was with HPV genotype 58, found in 10 % of participants. Conclusion. From the results of our research, we believe that detection and identifi cation of the broader spectrum of high-risk HPV genotypes will help to identify women who are likely to develop cervical cancer.
Cervical cancer is the second most common cancer in women worldwide. This type of cancer evolves from noninvasive intraepithelial stages, cervical intraepithelial neoplasia (CIN) grade 2 and 3, to invasive cancer. Infections with certain types of the carcinogenic human papilloma virus (HPV) have the highest risk of progressing CIN to cancer. 1, 2 More than 100 different HPV genotypes have been identifi ed, and of these, approximately 45 genotypes were detected in anogenital region. 3 The potentially high-risk HPV genotypes include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 , as defi ned by their prevalence in the CIN lesions and cervical cancers. 4, 5 Perhaps, there are also potentially high-risk types (26, 53, 66, 68, 73 and 82) as well. 4, 5 According to most investigators, cervical cancer occurs in women who had been previously infected with the so-called high-risk HPV genotypes; the prevalence of HPV infection in women with invasive form of cervical cancer is 99.7%. 6, 7 Because HPV cannot be cultured in vitro, and serological tests are ineffective, detection of the infection requires molecular methods. 8 The polymerase chain reaction (PCR) is the most sensitive and the most commonly used method for the detection of HPV infection and HPV genotyping. 9,10 Accordingly, we used HPV genotyping based on enzyme restriction of PCR products of products from restriction (restriction fragment length polymorphism (RFLP). 11 Numerous studies have established that the distribution of HPV genotypes differs with various geographical areas. The main objective of our study was to determine the range and frequency of HPV genotypes in women from Montenegro.
Methods
Cervical smears were taken from 189 patients with clinical signs of HPV infection (cervicitis chronica, erosio vera cervicis, erythroplakia portio vaginalis uteri, leukoplakia, tumor cervicitis). The samples were collected at the Clinical Center in Podgorica during 2005-2006, and HPV infection was established with a commercial diagnostic kit HC II (Digene Specimen Collection Kit, Silver Spring, Maryland, USA) at the Laboratory for Molecular Microbiology and Diagnostics of AIDS, Institute of Microbiology and Immunology, Faculty of Medicine in Ljubljana. The method involves detection of DNA HPV in cervical materials and amplifi cation by PCR. DNA from cervical samples was isolated by a procedure previously developed in that laboratory (12) . For the fi rst phase of PCR diagnostics, HPV DNA amplifi cation, we used two group-specifi c primers, MY09 and MY11. These two primers allow amplifi cation of a 450 bp conservative fragment of the HPV L1 gene. By using these primers we could identify more than 50 different HPV genotypes in a single PCR reaction. Specifi city of PCR products (amplicons) was then determined by gel-electrophoresis as previously described (13) .
HPV genotyping was established in HPV positive samples by enzyme restriction of PCR products and identifi cation of these by RFLP. Forty-four different restriction patterns of MY09/MY11 PCR products have been described, each specifi c for a particular HPV genotype. RFLP used seven different restriction endonucleases: BamHI, DdeI, HaeIII, DNA HinfI digest, PstI, RsaI and Sau3AI (Gibco-BRL, Bethesda, USA). Patterns of enzyme restriction of PCR products were then compared to predefi ned standard patterns of restriction to defi ne the genotype (13) .
Results
Out of 189 women included in our examined cohort, most (79%) were between ages of 20 to 45 years. These women were thus fully mature and likely to be sexually active. The average age of participants was 38 years; the youngest was 23 and the oldest was 68 years old.
HPV infection was found in 38 women out of the total 189 examined participants (20%). Genotyping of the HPV from these 38 infected women showed that the HPV genotype 16 was present in more than a third of the participants (Table  1 ). Among the HPV infected women, 31 of them had a single dominant HPV type ( Table 1 ). Six of the 38 infected individuals had two different HPV genotypes.
In our analysis of 16 detected HPV genotypes, we confi rmed that 31 out of 38 patients, or more than 80%, had high-risk HPV genotypes. Among the remaining infected individuals, samples from two women had genotypes that were probably high-risk, whereas fi ve others had low-risk HPV genotypes. We noted that out of 38 HPV DNA positive participants, the infection was most common in women aged 20-30 years (25/38). Ages in the older group (13/38) ranged 40-50 years. Seven women, aged 25 to 30 years, had multiple infections (Table 2 ). These included both high-risk and probably potentially high-risk HPV genotypes.
Discussion
Half the patients in our study were infected with two HPV genotypes, 16 and 58. These fi ndings indicate the need for a broader study of HPV infection and genotyping. The fact that meta-analysis of data published from 1995 to 2009 in 1,016.719 women showed that only fi ve types of HPV (16, 18, 31, 52 and 58) are most frequent genotypes 14 should stimulate further studies of our Montenegrin population.
Detection of HPV DNA is useful for triage of patients who have abnormal PAP test of cervical smears (15) . Early detection of HPV, followed by treatment of cervical dysplasia, can signifi cantly reduce the risk of developing cervical cancer (16) . In this regard, accurate detection of HPV infection is Additionally, information on the distribution of HPV genotypes in women in a particular country can instigate appropriate epidemiological monitoring of HPV genotype distribution in that country. Such information can facilitate application of vaccines effective against HPV. Studies show that HPV genotype 16 is the most prevalent (50-65%) in cervical cancer, while HPV genotype 18 occurs in 7-20% (4, 17, 18) . Given that HPV infection was diagnosed in 20% of the women enrolled in our study, the need for early and accurate detection of HPV infection seems apparent.
Epidemiology of HPV infection is a dynamic process; HPV infection can be acquired and eliminated over time. Hypothetically, the viruses can persist at very low levels and remain undiagnosed. Development of cervical lesions is likely associated with persistent HPV infection. Weakened immunity may also play a role, causing a rise in viral load, which, in turn, can result in multiple HPV infections. This hypothesis is supported by the observation that HIVinfected women with severely compromised immune systems have a prevalence of multiple HPV genotypes (20) .
We noted that HPV infections are more common in younger women than older ones. It is assumed that infection in this group increases as a result of an insuffi cient immune response to HPV infection. We also fi nd that multiple HPV infection (more than one HPV genotype) occurred more frequently in younger women and showed at least one highrisk or probably high-risk HPV genotype. Because young women with HPV infection are more likely to experience cofactor events (births, sexually transmitted diseases, etc.) that promote occurrence of cervical carcinoma, the need for HPV screening and typing seems obvious.
The combination of cytology and HPV testing is highly predictive for future CIN2+ disease and thus can be used to screen a presumed healthy population. 2 Our screening program, based only on detection of HPV 16 and HPV 18 for women in Montenegro, would be insuffi cient for identifying those individuals most likely to develop cervical cancer. In order to detect all high-risk HPV genotypes, the methodology should be expanded to include even minor components and used along with cervical cytology to improve screening results. Identifi cation of specifi c protein biomarkers (e.g., those are involved in cell cycle regulation, signal transduction, DNA replication, and cellular proliferation) may help to detect women at greatest risk for developing cervical cancer. Use of such biomarkers in both cervical cytology and histology could signifi cantly improve cervical screening by reducing false-negative and falsepositive results.
